Shernan Holtan: Latest Publication on PTCy
Shernan Holtan, Chief of Blood and Marrow Transplantation, Professor of Medicine at Roswell Park Comprehensive Cancer Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Cureus, adding::
“New to PTCy?
Read and bookmark our latest publication.
With most PTCy platforms, there is no immunosuppression given until PTCy starts on day plus 3.
That gives 3 days for those mature, potentially alloreactive T cells that went along for a ride with the stem cells in the infusion bag to throw a party.
Between infusion and day 3 (and sometimes later), that T cell party can lead to some pretty unique and even scary inflammatory manifestations.
The good news is that if you recognize the patterns, you can intervene and keep the patient safe.
Read our case report to learn more!”
Title: Early-Onset Hemophagocytic Lymphohistiocytosis and Inflammatory Neurotoxicity Prior to Post-transplant Cyclophosphamide: A Report of Two Cases
Authors: Kashish Shah, Brian C. Betts, Maureen Ross, Alicia Lieberman, Marco L. Davila, Shernan Holtan
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026